BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8380786)

  • 1. Liver metastases of gestational trophoblastic tumor.
    Bakri YN; Subhi J; Amer M; Ezzat A; Sinner W; Tweijry A; Jabbar FA
    Gynecol Oncol; 1993 Jan; 48(1):110-3. PubMed ID: 8380786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metastases of gestational trophoblastic tumor.
    Bakri Y; Berkowitz RS; Goldstein DP; Subhi J; Senoussi M; von Sinner W; Jabbar FA
    J Reprod Med; 1994 Mar; 39(3):179-84. PubMed ID: 7518516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and management of gestational trophoblastic tumor with liver metastases].
    Xiang Y; Yang X; Yang N; Chen C; Cao T; Song H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):41-3. PubMed ID: 12903491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
    Willemse PH; Aalders JG; Bouma J; Sleijfer DT
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
    Bilgin T; Ozan H; Ozuysal S; Ozkan L
    Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic metastases in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Obstet Gynecol; 1986 Jan; 67(1):107-11. PubMed ID: 2999663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
    Cagayan MS; Lu-Lasala LR
    J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; CantĂș MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.